NO300730B1 - Heksahydronaftalenesterderivater og farmasöytiske preparater inneholdende disse - Google Patents

Heksahydronaftalenesterderivater og farmasöytiske preparater inneholdende disse Download PDF

Info

Publication number
NO300730B1
NO300730B1 NO934852A NO934852A NO300730B1 NO 300730 B1 NO300730 B1 NO 300730B1 NO 934852 A NO934852 A NO 934852A NO 934852 A NO934852 A NO 934852A NO 300730 B1 NO300730 B1 NO 300730B1
Authority
NO
Norway
Prior art keywords
hydroxy
methyl
acid
ethyl
reaction
Prior art date
Application number
NO934852A
Other languages
English (en)
Norwegian (no)
Other versions
NO934852D0 (no
NO934852L (no
Inventor
Hiroshi Kogen
Sadao Ishihara
Teiichiro Koga
Eiichi Kitazawa
Nobufusa Serizawa
Kiyoshi Hamano
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO934852D0 publication Critical patent/NO934852D0/no
Publication of NO934852L publication Critical patent/NO934852L/no
Publication of NO300730B1 publication Critical patent/NO300730B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
    • C07C69/33—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with hydroxy compounds having more than three hydroxy groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0093—Oxidoreductases (1.) acting on CH or CH2 groups (1.17)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Indole Compounds (AREA)
NO934852A 1992-12-28 1993-12-27 Heksahydronaftalenesterderivater og farmasöytiske preparater inneholdende disse NO300730B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34903492 1992-12-28

Publications (3)

Publication Number Publication Date
NO934852D0 NO934852D0 (no) 1993-12-27
NO934852L NO934852L (no) 1994-06-29
NO300730B1 true NO300730B1 (no) 1997-07-14

Family

ID=18401049

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934852A NO300730B1 (no) 1992-12-28 1993-12-27 Heksahydronaftalenesterderivater og farmasöytiske preparater inneholdende disse

Country Status (23)

Country Link
US (2) US5451688A (fr)
EP (1) EP0605230B1 (fr)
JP (1) JPH06247894A (fr)
KR (1) KR100286596B1 (fr)
CN (1) CN1039642C (fr)
AT (1) ATE157346T1 (fr)
AU (1) AU670468B2 (fr)
CA (1) CA2112442A1 (fr)
CZ (1) CZ280492B6 (fr)
DE (1) DE69313427T2 (fr)
DK (1) DK0605230T3 (fr)
ES (1) ES2108238T3 (fr)
FI (1) FI935895A (fr)
GR (1) GR3025412T3 (fr)
HK (1) HK1000937A1 (fr)
HU (1) HU221845B1 (fr)
IL (1) IL108194A (fr)
MX (1) MX9400060A (fr)
NO (1) NO300730B1 (fr)
NZ (1) NZ250609A (fr)
RU (1) RU2104997C1 (fr)
TW (1) TW289753B (fr)
ZA (1) ZA939741B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0251582A (ja) * 1988-08-12 1990-02-21 Kyokado Eng Co Ltd 地盤注入用薬液
US5989877A (en) * 1995-08-03 1999-11-23 Gist-Brocades B.V. Selective process for the deacylation of acylated compounds
KR100186758B1 (ko) * 1996-08-09 1999-04-01 영진약품공업 주식회사 프라바스타틴(pravastatin)전구체의제조방법
CA2226996C (fr) * 1997-01-24 2006-08-15 Kose Corporation Composition cosmetique blanchissante a base d'alcool polyhydrique
AU737735B2 (en) * 1997-08-28 2001-08-30 Novartis Ag Lymphocyte function antigen-1 antagonists
US6682913B1 (en) 1999-02-03 2004-01-27 Institute For Drug Research Ltd. Microbial process for preparing pravastatin
CO5140104A1 (es) * 1999-02-16 2002-03-22 Novartis Ag Derivados de mevinolina y preparacion farmaceuticas que los contienen
JP3881240B2 (ja) * 1999-11-30 2007-02-14 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ 醗酵ブロスからスタチン化合物を回収するための方法
AU779306B2 (en) 1999-12-14 2005-01-13 Teva Gyogyszergyar Reszvenytarsasag Novel forms of pravastatin sodium
CN1468098A (zh) * 2000-10-05 2004-01-14 �ݰ¸Ƕ�ҩ�����޹�˾ 基本上无普伐他汀内酯和表普伐他汀的普伐他汀钠和包含普伐他汀钠的组合物
JP2002121172A (ja) * 2000-10-16 2002-04-23 Sankyo Co Ltd プラバスタチン又はその薬理上許容される塩の精製方法
JP3236282B1 (ja) * 2000-10-16 2001-12-10 三共株式会社 プラバスタチンを精製する方法
KR100458151B1 (ko) * 2001-05-14 2004-11-26 씨제이 주식회사 프락토실 트랜스퍼라제를 생산하는 신규 미생물 및 이를이용하여 프락토올리고당 및 네오프락토올리고당을생산하는 방법
ITMI20021327A1 (it) * 2002-06-14 2003-12-15 Recordati Chem Pharm Nuove ossialchilpiperazine
US7071197B2 (en) 2002-06-14 2006-07-04 Recordati S.A. N,N-disubstituted diazocycloalkanes
US7029178B2 (en) * 2002-10-04 2006-04-18 Ght Ventures, Llc Zip-lock closure
WO2005051372A2 (fr) 2003-11-24 2005-06-09 Teva Gyógyszergyár Zártköruen Muködo Részvénytársaság Procédé de purification de pravastatine
CN1277826C (zh) * 2003-12-01 2006-10-04 叶红平 辉伐他汀及其合成方法和以辉伐他汀为原料药的制剂
US20070185193A1 (en) * 2003-12-01 2007-08-09 Huaibei Huike Pharmaceutical, Co. Ltd. Huvastatin and its preparation and formulation comprising the huvastatin
WO2005121062A2 (fr) * 2004-06-09 2005-12-22 Ranbaxy Laboratories Limited Procede d'elaboration de pravastatine
US7714017B2 (en) * 2004-10-12 2010-05-11 Decode Genetics, Ehf Carboxylic acid peri-substituted bicyclics for occlusive artery disease
TWI307360B (en) 2004-12-03 2009-03-11 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Process for constructing strain having compactin hydroxylation ability
US20090068325A1 (en) * 2007-09-10 2009-03-12 Gil Depicciotto Method of treatment of fresh produce
EP2241561A1 (fr) * 2009-04-16 2010-10-20 Neuron Biopharma, S.A. Composé neuroprotecteur, hypocholestérolémiant et antiépileptique
ES2380473B1 (es) * 2010-10-13 2013-02-19 Neuron Biopharma, S.A. Compuesto neuroprotector, hipocolesterolémico, antiinflamatorio y antiepiléptico.
WO2014148455A1 (fr) * 2013-03-19 2014-09-25 第一三共株式会社 Dérivé terpénoïde
CN108546721B (zh) * 2018-04-20 2021-04-13 安徽大学 一种利用微生物合成对羟基苯甲酸的方法
US20240150279A1 (en) * 2021-02-01 2024-05-09 The University Of Toledo C prime agents for treating metabolic disorders
CN114250254B (zh) * 2021-12-20 2024-01-05 宁夏清研高分子新材料有限公司 一种对羟基苯甲酸的微生物合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH381478A (de) * 1959-11-21 1964-08-31 Atkinsons Agricultural Appl Sicherheitsschutzvorrichtung für Gelenkwellenkupplungen
US4137322A (en) * 1976-11-02 1979-01-30 Sankyo Company Limited ML-236B carboxylic acid derivatives and their use as antihyperlipemic agents
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
JPS5810572A (ja) * 1981-07-07 1983-01-21 Sankyo Co Ltd Ｍｌ−２３６ｂ誘導体およびその製造法
JPS5889191A (ja) * 1981-11-20 1983-05-27 Sankyo Co Ltd ３−ヒドロキシ−ｍｌ−２３６ｂ誘導体の製造法
JPS5917545A (ja) * 1982-07-22 1984-01-28 Canon Inc オ−トフオ−カスカメラの距離表示機構
JPS59175450A (ja) * 1983-03-24 1984-10-04 Sankyo Co Ltd Ｍｌ−２３６ｂ誘導体
US4997848A (en) * 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
US5049696A (en) * 1988-04-11 1991-09-17 Merck & Co., Inc. Antihypercholesterolemic compounds
EP0381478A1 (fr) * 1989-02-01 1990-08-08 Merck & Co. Inc. Procédé de préparation de dérivés de 6-alpha-hydroxyméthyl-lovastatine
GB8915280D0 (en) * 1989-07-04 1989-08-23 British Bio Technology Compounds
GB9007738D0 (en) * 1990-04-05 1990-06-06 British Bio Technology Compounds
GB9100174D0 (en) * 1991-01-04 1991-02-20 British Bio Technology Compounds
IL108432A (en) * 1993-01-29 1997-09-30 Sankyo Co DERIVATIVES OF 3, 5-DIHYDROXY-7- £1, 2, 6, 7, 8, 8a-HEXAHYDRO-2- METHYL-8- (SUBSTITUTED ALKANOYLOXY)-1-NAPHTHYL| HEPTANOIC ACID AND THEIR LACTONES, THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
FI935895A (fi) 1994-10-19
CA2112442A1 (fr) 1994-06-29
HK1000937A1 (en) 1998-05-08
HU221845B1 (hu) 2003-02-28
NO934852D0 (no) 1993-12-27
ZA939741B (en) 1994-08-15
US5827855A (en) 1998-10-27
RU2104997C1 (ru) 1998-02-20
HUT65593A (en) 1994-07-28
US5451688A (en) 1995-09-19
CZ280492B6 (cs) 1996-01-17
KR100286596B1 (ko) 2001-04-16
GR3025412T3 (en) 1998-02-27
ATE157346T1 (de) 1997-09-15
DE69313427T2 (de) 1998-03-26
CZ290093A3 (en) 1994-08-17
CN1039642C (zh) 1998-09-02
JPH06247894A (ja) 1994-09-06
MX9400060A (es) 1994-07-29
NO934852L (no) 1994-06-29
TW289753B (fr) 1996-11-01
EP0605230A1 (fr) 1994-07-06
FI935895A0 (fi) 1993-12-28
IL108194A (en) 1998-02-22
DE69313427D1 (de) 1997-10-02
NZ250609A (en) 1995-07-26
AU5269993A (en) 1994-07-07
CN1094707A (zh) 1994-11-09
KR940014294A (ko) 1994-07-18
AU670468B2 (en) 1996-07-18
EP0605230B1 (fr) 1997-08-27
ES2108238T3 (es) 1997-12-16
DK0605230T3 (da) 1998-04-20
IL108194A0 (en) 1994-04-12
HU9303762D0 (en) 1994-04-28

Similar Documents

Publication Publication Date Title
NO300730B1 (no) Heksahydronaftalenesterderivater og farmasöytiske preparater inneholdende disse
JPH0371116B2 (fr)
DK149080B (da) Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
JPH0371419B2 (fr)
JP2007291075A (ja) 新規化合物ステレニン及びその製造方法
EP0099692A1 (fr) Dérivés de furanone, procédé pour leur préparation et leur utilisation
JPH0622780A (ja) 新規真菌株及びそれを用いた抗生物質産生方法
EP0215665B1 (fr) Dérivés de l'hydroxy-ML-236B, leur production et utilisation
KR100648541B1 (ko) 프라바스타틴을 제조하기 위한 미생물학적인 방법
AU653384B2 (en) Polyhydroxycyclopentane derivatives, their preparation and their therapeutic use
NO300769B1 (no) Heksahydronaftalenesterderivater og farmasöytiske preparater inneholdende disse
RU2125043C1 (ru) Производные октагидронафталиноксима, фармацевтическая композиция, способ лечения и способ их получения
JP2004083570A (ja) 低酸素応答誘導剤およびその製法
JPH0366297B2 (fr)
JPH08208646A (ja) 化合物ｂ９００６３
JPH0482135B2 (fr)